Skip to main content

Becton Dickinson and Company(BDX-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low164.33
Day High169.42
Open:168.26
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

TOP STORIES: Becton Dickinson and Company

Select a category then submit the form to load news
Analysts Offer Insights on Healthcare Companies: Astrana Health (ASTH), Becton Dickinson (BDX) and United Therapeutics (UTHR)
Analysts’ Top Healthcare Picks: Becton Dickinson (BDX), United Therapeutics (UTHR)
Analysts Are Bullish on Top Healthcare Stocks: Arcutis Biotherapeutics (ARQT), Kymera Therapeutics (KYMR)
RBC Capital Keeps Their Hold Rating on Becton Dickinson (BDX)
Becton Dickinson Expands Debt Tender Offers Amid Strong Demand
Becton Dickinson (BDX) Gets a Buy from Jefferies
J.P. Morgan Reaffirms Their Hold Rating on Becton Dickinson (BDX)
Becton Dickinson Launches $1.6 Billion Debt Tender Offers
Waters resumed with an In Line at Evercore ISI
Wells Fargo Keeps Their Hold Rating on Becton Dickinson (BDX)
RBC Capital Remains a Hold on Becton Dickinson (BDX)
Becton, Dickinson Earnings Call: Growth Amid Tariff Drag
BD Reorganizes into Five Global Business Segments
Becton Dickinson Creates New Preferred Stock for Spin-Off
Analysts Offer Insights on Healthcare Companies: Tenet Healthcare (THC) and Becton Dickinson (BDX)
Becton Dickinson adopts executive severance plan, equity increase
Analysts’ Top Healthcare Picks: Becton Dickinson (BDX), Regeneron (REGN)
BD’s BD Prevue II Study Wraps Up: What a Post‑Market Win Could Mean for BDX Investors
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Becton Dickinson (BDX) and Moderna (MRNA)
BDX’s SiteRite 9 Study Completion: What Investors Should Know About This Post‑Market Milestone
RBC Capital Reaffirms Their Hold Rating on Becton Dickinson (BDX)

Profile

Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.